However, sometime in 2021, a new plan emerged to further accelerate research by turning the idea into a well-funded company, and that is now Altos. The effort took shape under the direction of Richard Klausner, once chief of the National Cancer Institute and now an entrepreneur. Klausner, who previously helped found similar companies, Juno Therapeutics […]